Novel genome editing strategy to treat genetic disorders
Start date project: 2023
Involved institutes: LUMC
Stage: Preclinical
Status: Ongoing
AAV Stealth switch for applications in gene therapy
Start date project: 2022
Involved institutes: LUMC, KNAW
Stage: Preclinical
Status: Ongoing
Establishment of a clinical grade human iPS cell line
Start project: 2020
Involved institutes: LUMC, NECSTGEN
Stage: Preclinical
Status: Ongoing
Reversibly Immortalizable Cardiomyocytes
Start date project: 2018
Involved institutes: LUMC
Status: Ongoing